- Home
- RVPH vs STI Comparison
RVPH vs STI Comparison
Compare RVPH & STI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- STI
- Stock Information
- Founded
- RVPH 2006
- STI 2014
- Country
- RVPH United States
- STI United States
- Employees
- RVPH N/A
- STI N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- STI
- Sector
- RVPH Health Care
- STI
- Exchange
- RVPH Nasdaq
- STI NYSE
- Market Cap
- RVPH 32.8M
- STI 9.5M
- IPO Year
- RVPH N/A
- STI N/A
- Fundamental
- Price
- RVPH $0.36
- STI $3.71
- Analyst Decision
- RVPH Strong Buy
- STI
- Analyst Count
- RVPH 5
- STI 0
- Target Price
- RVPH $9.00
- STI N/A
- AVG Volume (30 Days)
- RVPH 2.4M
- STI 86.4K
- Earning Date
- RVPH 08-13-2025
- STI 08-12-2025
- Dividend Yield
- RVPH N/A
- STI N/A
- EPS Growth
- RVPH N/A
- STI N/A
- EPS
- RVPH N/A
- STI 6.72
- Revenue
- RVPH N/A
- STI N/A
- Revenue This Year
- RVPH N/A
- STI N/A
- Revenue Next Year
- RVPH N/A
- STI N/A
- P/E Ratio
- RVPH N/A
- STI $0.59
- Revenue Growth
- RVPH N/A
- STI N/A
- 52 Week Low
- RVPH $0.30
- STI $2.94
- 52 Week High
- RVPH $4.28
- STI $55.00
- Technical
- Relative Strength Index (RSI)
- RVPH 29.52
- STI 52.53
- Support Level
- RVPH $0.30
- STI $3.22
- Resistance Level
- RVPH $0.83
- STI $4.54
- Average True Range (ATR)
- RVPH 0.07
- STI 0.25
- MACD
- RVPH -0.04
- STI 0.12
- Stochastic Oscillator
- RVPH 11.25
- STI 59.09
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About STI SOLIDION TECHNOLOGY INC
Solidion Technology Inc is engaged in researching, developing and manufacturing battery materials and components, as well as the development and production of next-generation batteries for energy storage systems and electric vehicles for ground, air, and sea transportation. It is recognized as a IP leader in both the high-capacity anode and the high-energy solid-state battery.